Tower Research Capital LLC (Trc) Soleno Therapeutics Inc Transaction History

Tower Research Capital LLC (Trc)

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.14 - $0.23 $533 - $876	-3,809 Reduced 51.24%	3,624 $1,000
Q1 2022 May 12, 2022	BUY	$0.22 - $0.47 $582 - $1,244	2,647 Added 55.31%	7,433 $2,000
Q4 2021 Feb 14, 2022	BUY	$0.41 - $0.91 $1,962 - $4,355	4,786 New	4,786 $2,000
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.12 $14,710 - $20,594	-18,388 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$0.97 - $1.32 $51,782 - $70,466	-53,384 Reduced 74.38%	18,388 $21,000
Q1 2021 May 17, 2021	BUY	$1.24 - $3.3 $80,518 - $214,282	64,934 Added 949.61%	71,772 $90,000
Q4 2020 Feb 16, 2021	SELL	$1.61 - $2.23 $49,171 - $68,106	-30,541 Reduced 81.71%	6,838 $13,000
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.51 $53,640 - $78,736	31,369 Added 521.95%	37,379 $94,000
Q2 2020 Aug 13, 2020	BUY	$1.77 - $4.23 $10,637 - $25,422	6,010 New	6,010 $13,000
Q1 2019 May 14, 2019	SELL	$1.35 - $2.68 $3,164 - $6,281	-2,344 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.55 - $2.3 $3,633 - $5,391	2,344 New	2,344 $4,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $468M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.